Carl Stefan Fraenkel
Directeur/Membre du Conseil chez Akinion Pharmaceuticals AB
Postes actifs de Carl Stefan Fraenkel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Carl Stefan Fraenkel
Anciens postes connus de Carl Stefan Fraenkel
Sociétés | Poste | Début | Fin |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 23/02/2011 | - |
Formation de Carl Stefan Fraenkel
Copenhagen Business School | Doctorate Degree |
Chalmers University of Technology | Undergraduate Degree |
Statistiques
Internationale
Suède | 4 |
Danemark | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Entreprise privées | 1 |
---|---|
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
- Bourse
- Insiders
- Carl Stefan Fraenkel
- Expérience